Literature DB >> 3142541

Surveillance of antibody to measles, mumps, and rubella by age.

P Morgan-Capner1, J Wright, C L Miller, E Miller.   

Abstract

Before the introduction of measles, mumps, and rubella vaccine a survey was carried out to measure antibody prevalence to the three viruses by age. A total of 8716 samples of serum collected by five public health laboratories in different parts of England during 1986-7 were tested. Despite the current measles vaccination programme 60% of children aged 1-2 years did not have measles antibody and over 80% did not have antibodies to mumps and rubella. In the 3-4 year age group 17% of the children were susceptible to measles, 55% to mumps, and 73% to rubella. The results suggest that vaccinating children early in the second year of life will be necessary to eliminate the three diseases. The survey provides baseline data for continuing surveillance of the immediate and long term effects of the new vaccination strategy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142541      PMCID: PMC1834398          DOI: 10.1136/bmj.297.6651.770

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  3 in total

1.  Scandinavian model for eliminating measles, mumps, and rubella.

Authors:  E Rabo; J Taranger
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

2.  Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories.

Authors:  J B Kurtz; P P Mortimer; P R Mortimer; P Morgan-Capner; M S Shafi; G B White
Journal:  J Hyg (Lond)       Date:  1980-04

3.  Rubella epidemiology in South East England.

Authors:  D J Nokes; R M Anderson; M J Anderson
Journal:  J Hyg (Lond)       Date:  1986-04
  3 in total
  20 in total

1.  Measles, mumps, and rubella vaccine: time for a two stage policy?

Authors:  H Carter; D Gorman
Journal:  BMJ       Date:  1992-03-07

Review 2.  Rubella in Europe.

Authors:  A Galazka
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 3.  Rubella in the United Kingdom.

Authors:  E Miller
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

4.  Serological study of the epidemiology of mumps virus infection in north-west England.

Authors:  D J Nokes; J Wright; P Morgan-Capner; R M Anderson
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

5.  Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.

Authors:  N J Gay; L M Hesketh; P Morgan-Capner; E Miller
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

Review 6.  Monitoring the prevalence of HIV.

Authors:  O N Gill; M W Adler; N E Day
Journal:  BMJ       Date:  1989-11-25

Review 7.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

Authors:  S E Robertson; F T Cutts; R Samuel; J L Diaz-Ortega
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

8.  Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.

Authors:  H R Babad; D J Nokes; N J Gay; E Miller; P Morgan-Capner; R M Anderson
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

9.  The new measles campaign.

Authors:  E Miller
Journal:  BMJ       Date:  1994-10-29

10.  Seroepidemiology of group C rotavirus infection in England and Wales.

Authors:  Miren Iturriza-Gómara; Ian Clarke; Ulrich Desselberger; David Brown; Daniel Thomas; Jim Gray
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.